| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO And CFO | Chief Financial Officer | See Remarks +1 more
2 companies
Quinn William P. serves as a See Remarks at VIRX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 14 buys and 0 sells. Those positions are worth an estimated $56K at current prices.
Historically, Quinn William P.'s trades have earned a below-average insider score of 36/100 across 10 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -55.4%.
The biggest single holding is VIRX (~$47K) as See Remarks. Net of sales, the recent Form 4 record there shows accumulation of 52,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | BOLT Bolt Biotherapeutics, Inc. | President, CEO And CFO | Buy | 125 | $4.61 | $575.88 | +5.7% | -19.6% | - | |
| Jun 6, 2025 | BOLT Bolt Biotherapeutics, Inc. | President, CEO And CFO | Buy | 125 | $5.49 | $686.50 | +6.1% | -25.1% | -29.4% | |
| Dec 16, 2024 | BOLT Bolt Biotherapeutics, Inc. | President, CEO And CFO | Buy | 5,000 | $0.57 | $2,834.75 | +6.7% | -20.8% | -47.4% | |
| Dec 12, 2023 | BOLT Bolt Biotherapeutics, Inc. | Chief Financial Officer | Buy | 11,829 | $0.95 | $11,240.96 | +14.9% | +28.6% | -43.6% | |
| Dec 8, 2021 | BOLT Bolt Biotherapeutics, Inc. | Chief Financial Officer | Buy | 6,256 | $7.04 | $44,067.05 | +14.2% | -37.3% | -70.8% | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | Chief Financial Officer | Buy | 1,200 | $20.00 | $24,000.00 | +9.5% | - | - | |
| Nov 29, 2019 | VIRX Viracta Therapeutics, Inc. | See Remarks | Buy | 12,000 | $0.51 | $6,069.60 | +5.1% | - | - | |
| Dec 10, 2018 | VIRX Viracta Therapeutics, Inc. | CFO,Sr.v.p. Finance, Corp.dev. | Buy | 40,000 | $0.47 | $18,800.00 | +333.3% | - | - |